ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 131

Reflections on the Creation of a Transition Clinic and the First 6-months of a Registry for Young Adults with Juvenile Idiopathic Arthritis: The Women’s College Hospital Experience

Y. Ingrid Goh1, Evelyn Rozenblyum2, Shabiga Ragunathan3, Sabrina Agostini3, Tara Stier3, Brian Feldman1, Lynn Spiegel4, Kristi Whitney1, Jo-Anne Marcuz1, Deborah Levy1, Ronald M. Laxer1, Shirley M. Tse1, Jennifer JY Lee5, Elizaveta Limenis1, Ruud Verstegen1 and Natasha Gakhal2, 1The Hospital for Sick Children, Toronto, ON, Canada, 2Women's College Hospital, Toronto, ON, Canada, 3Women's College Hospital, 4The Hospital for Sick Children; University of Toronto, Toronto, ON, Canada, 5The Hospital for Sick Children, Unionville, ON, Canada

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Friday, March 20, 2026

Title: Posters: Quality, Health Services, and Education Research II

Session Time: 5:00PM-6:00PM

Background/Purpose: Transfer from pediatric to adult healthcare for young adults with rheumatic conditions occurs during a period of significant change. Preparedness and self-management skills influence follow-up care—up to 50% may be lost to follow-up at time of transfer, risking poor health outcomes. Transition clinics can provide coordinated, developmentally appropriate continuity of care, where young adults are seen jointly by pediatric and adult rheumatologists during these vulnerable years. Our aim is to report on the creation of a young adult clinic dedicated to supporting the transition of individuals diagnosed with juvenile idiopathic arthritis (JIA), as well as a registry to enable research and quality improvement.

Methods: Discussions and needs assessment were conducted prior to establishing the clinic to determine its aims, patient population, capacity, infrastructure, workforce planning, location, and feasibility.
The clinic was modeled after the Young Adult with Rheumatic Diseases clinic at BC Children’s Hospital as a shared-care clinic with pediatric and adult providers.
To evaluate the clinic’s impact, a registry was developed in collaboration with pediatric and adult teams to systematically collect data on attendees’ engagement and health outcomes.

Results: The Women’s College Hospital Young Adult Clinic opened in 2019 and is staffed by a pediatric rheumatologist, an adult rheumatologist, and an advanced-practice occupational therapy practitioner. From 2019 to 2025, the clinic has followed 225 patients.
The JIA Young Adult Clinic Helping Transition (JIA YACHT) registry was created and modeled after the Canadian Arthritis Network Disease Impact and Outcomes (CANDIO) registry at The Hospital for Sick Children. Recruitment began in May 2025, and since its inception, 69 participants have been enrolled. Of these, 56 (80%) were female, and 53 (77%) were receiving biologics, biosimilars, or disease-modifying antirheumatic drugs (DMARDs). The median swollen joint count was 0 (range: 0–14), the median physician global assessment score was 3 (range: 0–8), the median patient global assessment score was 2 (range: 0–8), and the median pain score was 2.5 (range: 0–9). The median time from referral to the first clinic visit for registry participants was 134 days. The registry has proven to be an effective tool for monitoring important health outcomes post-transfer, such as uveitis status.

Conclusion: The creation of a dedicated transition clinic and registry has provided a strategic approach to transferring young adults with JIA from pediatric to adult care. This first-in-Canada transition registry enables standardized, systematic monitoring and evaluation of post-transfer care processes, identification of practice gaps, and tracking of patient outcomes. These insights will inform best practices and support ongoing improvements in transitional care.


Disclosures: Y. Goh: None; E. Rozenblyum: None; S. Ragunathan: None; S. Agostini: None; T. Stier: None; B. Feldman: None; L. Spiegel: None; K. Whitney: None; J. Marcuz: None; D. Levy: None; R. Laxer: Akros pharma, 2, Celltrion, 2, Eli Lilly, 2, Novartis, 2, Sanofi-Aventis, 1, 2, UpToDate, 9; S. Tse: None; J. Lee: None; E. Limenis: None; R. Verstegen: None; N. Gakhal: AbbVie/Abbott, 1, 2, 5, 6, AstraZeneca, 1, celltrion, 1, Janssen, 6, lily, 1, novaritis, 1, 2, 6, Pfizer, 1, 2, 5, 6, sandoz, 6.

To cite this abstract in AMA style:

Goh Y, Rozenblyum E, Ragunathan S, Agostini S, Stier T, Feldman B, Spiegel L, Whitney K, Marcuz J, Levy D, Laxer R, Tse S, Lee J, Limenis E, Verstegen R, Gakhal N. Reflections on the Creation of a Transition Clinic and the First 6-months of a Registry for Young Adults with Juvenile Idiopathic Arthritis: The Women’s College Hospital Experience [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/reflections-on-the-creation-of-a-transition-clinic-and-the-first-6-months-of-a-registry-for-young-adults-with-juvenile-idiopathic-arthritis-the-womens-college-hospital-experience/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reflections-on-the-creation-of-a-transition-clinic-and-the-first-6-months-of-a-registry-for-young-adults-with-juvenile-idiopathic-arthritis-the-womens-college-hospital-experience/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology